Global Influenza Vaccines Market Insight and Forecast to 2026
The research team projects that the Influenza Vaccines market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
AstraZeneca
FOLIA BIOTECH
Sanofi
CSL
FluGen
GlaxoSmithKline
Green Cross
BionVax
Altimmune
Genentech
SK Chemicals
Vaxart
Medicago
Visterra
UNM Pharma
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
Vaxine Pty
Vaccitech
Novavax
By Type
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
By Application
Adults
Pediatrics
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Influenza Vaccines 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Influenza Vaccines Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Influenza Vaccines Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Influenza Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
AstraZeneca
FOLIA BIOTECH
Sanofi
CSL
FluGen
GlaxoSmithKline
Green Cross
BionVax
Altimmune
Genentech
SK Chemicals
Vaxart
Medicago
Visterra
UNM Pharma
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
Vaxine Pty
Vaccitech
Novavax
By Type
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
By Application
Adults
Pediatrics
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Influenza Vaccines 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Influenza Vaccines Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Influenza Vaccines Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Influenza Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Trivalent Flu Vaccines
1.4.3 Quadrivalent Flu Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccines Market Share by Application: 2021-2026
1.5.2 Adults
1.5.3 Pediatrics
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Influenza Vaccines Market Perspective (2021-2026)
2.2 Influenza Vaccines Growth Trends by Regions
2.2.1 Influenza Vaccines Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Influenza Vaccines Historic Market Size by Regions (2015-2020)
2.2.3 Influenza Vaccines Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Influenza Vaccines Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Influenza Vaccines Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Influenza Vaccines Average Price by Manufacturers (2015-2020)
4 INFLUENZA VACCINES PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Influenza Vaccines Market Size (2015-2026)
4.1.2 Influenza Vaccines Key Players in North America (2015-2020)
4.1.3 North America Influenza Vaccines Market Size by Type (2015-2020)
4.1.4 North America Influenza Vaccines Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Influenza Vaccines Market Size (2015-2026)
4.2.2 Influenza Vaccines Key Players in East Asia (2015-2020)
4.2.3 East Asia Influenza Vaccines Market Size by Type (2015-2020)
4.2.4 East Asia Influenza Vaccines Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Influenza Vaccines Market Size (2015-2026)
4.3.2 Influenza Vaccines Key Players in Europe (2015-2020)
4.3.3 Europe Influenza Vaccines Market Size by Type (2015-2020)
4.3.4 Europe Influenza Vaccines Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Influenza Vaccines Market Size (2015-2026)
4.4.2 Influenza Vaccines Key Players in South Asia (2015-2020)
4.4.3 South Asia Influenza Vaccines Market Size by Type (2015-2020)
4.4.4 South Asia Influenza Vaccines Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Influenza Vaccines Market Size (2015-2026)
4.5.2 Influenza Vaccines Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Influenza Vaccines Market Size by Type (2015-2020)
4.5.4 Southeast Asia Influenza Vaccines Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Influenza Vaccines Market Size (2015-2026)
4.6.2 Influenza Vaccines Key Players in Middle East (2015-2020)
4.6.3 Middle East Influenza Vaccines Market Size by Type (2015-2020)
4.6.4 Middle East Influenza Vaccines Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Influenza Vaccines Market Size (2015-2026)
4.7.2 Influenza Vaccines Key Players in Africa (2015-2020)
4.7.3 Africa Influenza Vaccines Market Size by Type (2015-2020)
4.7.4 Africa Influenza Vaccines Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Influenza Vaccines Market Size (2015-2026)
4.8.2 Influenza Vaccines Key Players in Oceania (2015-2020)
4.8.3 Oceania Influenza Vaccines Market Size by Type (2015-2020)
4.8.4 Oceania Influenza Vaccines Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Influenza Vaccines Market Size (2015-2026)
4.9.2 Influenza Vaccines Key Players in South America (2015-2020)
4.9.3 South America Influenza Vaccines Market Size by Type (2015-2020)
4.9.4 South America Influenza Vaccines Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Influenza Vaccines Market Size (2015-2026)
4.10.2 Influenza Vaccines Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Influenza Vaccines Market Size by Type (2015-2020)
4.10.4 Rest of the World Influenza Vaccines Market Size by Application (2015-2020)
5 INFLUENZA VACCINES CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Influenza Vaccines Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Influenza Vaccines Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Influenza Vaccines Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Influenza Vaccines Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Influenza Vaccines Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Influenza Vaccines Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Influenza Vaccines Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Influenza Vaccines Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Influenza Vaccines Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Influenza Vaccines Consumption by Countries
5.10.2 Kazakhstan
6 INFLUENZA VACCINES SALES MARKET BY TYPE (2015-2026)
6.1 Global Influenza Vaccines Historic Market Size by Type (2015-2020)
6.2 Global Influenza Vaccines Forecasted Market Size by Type (2021-2026)
7 INFLUENZA VACCINES CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Influenza Vaccines Historic Market Size by Application (2015-2020)
7.2 Global Influenza Vaccines Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN INFLUENZA VACCINES BUSINESS
8.1 AstraZeneca
8.1.1 AstraZeneca Company Profile
8.1.2 AstraZeneca Influenza Vaccines Product Specification
8.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 FOLIA BIOTECH
8.2.1 FOLIA BIOTECH Company Profile
8.2.2 FOLIA BIOTECH Influenza Vaccines Product Specification
8.2.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Sanofi
8.3.1 Sanofi Company Profile
8.3.2 Sanofi Influenza Vaccines Product Specification
8.3.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 CSL
8.4.1 CSL Company Profile
8.4.2 CSL Influenza Vaccines Product Specification
8.4.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 FluGen
8.5.1 FluGen Company Profile
8.5.2 FluGen Influenza Vaccines Product Specification
8.5.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Company Profile
8.6.2 GlaxoSmithKline Influenza Vaccines Product Specification
8.6.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Green Cross
8.7.1 Green Cross Company Profile
8.7.2 Green Cross Influenza Vaccines Product Specification
8.7.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 BionVax
8.8.1 BionVax Company Profile
8.8.2 BionVax Influenza Vaccines Product Specification
8.8.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Altimmune
8.9.1 Altimmune Company Profile
8.9.2 Altimmune Influenza Vaccines Product Specification
8.9.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Genentech
8.10.1 Genentech Company Profile
8.10.2 Genentech Influenza Vaccines Product Specification
8.10.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 SK Chemicals
8.11.1 SK Chemicals Company Profile
8.11.2 SK Chemicals Influenza Vaccines Product Specification
8.11.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Vaxart
8.12.1 Vaxart Company Profile
8.12.2 Vaxart Influenza Vaccines Product Specification
8.12.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Medicago
8.13.1 Medicago Company Profile
8.13.2 Medicago Influenza Vaccines Product Specification
8.13.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Visterra
8.14.1 Visterra Company Profile
8.14.2 Visterra Influenza Vaccines Product Specification
8.14.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 UNM Pharma
8.15.1 UNM Pharma Company Profile
8.15.2 UNM Pharma Influenza Vaccines Product Specification
8.15.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Shijiazhuang Yiling Pharmaceutical
8.16.1 Shijiazhuang Yiling Pharmaceutical Company Profile
8.16.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
8.16.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Moderna Therapeutics
8.17.1 Moderna Therapeutics Company Profile
8.17.2 Moderna Therapeutics Influenza Vaccines Product Specification
8.17.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Vaxine Pty
8.18.1 Vaxine Pty Company Profile
8.18.2 Vaxine Pty Influenza Vaccines Product Specification
8.18.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Vaccitech
8.19.1 Vaccitech Company Profile
8.19.2 Vaccitech Influenza Vaccines Product Specification
8.19.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.20 Novavax
8.20.1 Novavax Company Profile
8.20.2 Novavax Influenza Vaccines Product Specification
8.20.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Influenza Vaccines (2021-2026)
9.2 Global Forecasted Revenue of Influenza Vaccines (2021-2026)
9.3 Global Forecasted Price of Influenza Vaccines (2015-2026)
9.4 Global Forecasted Production of Influenza Vaccines by Region (2021-2026)
9.4.1 North America Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.3 Europe Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.7 Africa Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.9 South America Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Influenza Vaccines by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Influenza Vaccines by Country
10.2 East Asia Market Forecasted Consumption of Influenza Vaccines by Country
10.3 Europe Market Forecasted Consumption of Influenza Vaccines by Countriy
10.4 South Asia Forecasted Consumption of Influenza Vaccines by Country
10.5 Southeast Asia Forecasted Consumption of Influenza Vaccines by Country
10.6 Middle East Forecasted Consumption of Influenza Vaccines by Country
10.7 Africa Forecasted Consumption of Influenza Vaccines by Country
10.8 Oceania Forecasted Consumption of Influenza Vaccines by Country
10.9 South America Forecasted Consumption of Influenza Vaccines by Country
10.10 Rest of the world Forecasted Consumption of Influenza Vaccines by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Influenza Vaccines Distributors List
11.3 Influenza Vaccines Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Influenza Vaccines Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Trivalent Flu Vaccines
1.4.3 Quadrivalent Flu Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccines Market Share by Application: 2021-2026
1.5.2 Adults
1.5.3 Pediatrics
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Influenza Vaccines Market Perspective (2021-2026)
2.2 Influenza Vaccines Growth Trends by Regions
2.2.1 Influenza Vaccines Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Influenza Vaccines Historic Market Size by Regions (2015-2020)
2.2.3 Influenza Vaccines Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Influenza Vaccines Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Influenza Vaccines Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Influenza Vaccines Average Price by Manufacturers (2015-2020)
4 INFLUENZA VACCINES PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Influenza Vaccines Market Size (2015-2026)
4.1.2 Influenza Vaccines Key Players in North America (2015-2020)
4.1.3 North America Influenza Vaccines Market Size by Type (2015-2020)
4.1.4 North America Influenza Vaccines Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Influenza Vaccines Market Size (2015-2026)
4.2.2 Influenza Vaccines Key Players in East Asia (2015-2020)
4.2.3 East Asia Influenza Vaccines Market Size by Type (2015-2020)
4.2.4 East Asia Influenza Vaccines Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Influenza Vaccines Market Size (2015-2026)
4.3.2 Influenza Vaccines Key Players in Europe (2015-2020)
4.3.3 Europe Influenza Vaccines Market Size by Type (2015-2020)
4.3.4 Europe Influenza Vaccines Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Influenza Vaccines Market Size (2015-2026)
4.4.2 Influenza Vaccines Key Players in South Asia (2015-2020)
4.4.3 South Asia Influenza Vaccines Market Size by Type (2015-2020)
4.4.4 South Asia Influenza Vaccines Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Influenza Vaccines Market Size (2015-2026)
4.5.2 Influenza Vaccines Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Influenza Vaccines Market Size by Type (2015-2020)
4.5.4 Southeast Asia Influenza Vaccines Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Influenza Vaccines Market Size (2015-2026)
4.6.2 Influenza Vaccines Key Players in Middle East (2015-2020)
4.6.3 Middle East Influenza Vaccines Market Size by Type (2015-2020)
4.6.4 Middle East Influenza Vaccines Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Influenza Vaccines Market Size (2015-2026)
4.7.2 Influenza Vaccines Key Players in Africa (2015-2020)
4.7.3 Africa Influenza Vaccines Market Size by Type (2015-2020)
4.7.4 Africa Influenza Vaccines Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Influenza Vaccines Market Size (2015-2026)
4.8.2 Influenza Vaccines Key Players in Oceania (2015-2020)
4.8.3 Oceania Influenza Vaccines Market Size by Type (2015-2020)
4.8.4 Oceania Influenza Vaccines Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Influenza Vaccines Market Size (2015-2026)
4.9.2 Influenza Vaccines Key Players in South America (2015-2020)
4.9.3 South America Influenza Vaccines Market Size by Type (2015-2020)
4.9.4 South America Influenza Vaccines Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Influenza Vaccines Market Size (2015-2026)
4.10.2 Influenza Vaccines Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Influenza Vaccines Market Size by Type (2015-2020)
4.10.4 Rest of the World Influenza Vaccines Market Size by Application (2015-2020)
5 INFLUENZA VACCINES CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Influenza Vaccines Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Influenza Vaccines Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Influenza Vaccines Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Influenza Vaccines Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Influenza Vaccines Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Influenza Vaccines Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Influenza Vaccines Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Influenza Vaccines Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Influenza Vaccines Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Influenza Vaccines Consumption by Countries
5.10.2 Kazakhstan
6 INFLUENZA VACCINES SALES MARKET BY TYPE (2015-2026)
6.1 Global Influenza Vaccines Historic Market Size by Type (2015-2020)
6.2 Global Influenza Vaccines Forecasted Market Size by Type (2021-2026)
7 INFLUENZA VACCINES CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Influenza Vaccines Historic Market Size by Application (2015-2020)
7.2 Global Influenza Vaccines Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN INFLUENZA VACCINES BUSINESS
8.1 AstraZeneca
8.1.1 AstraZeneca Company Profile
8.1.2 AstraZeneca Influenza Vaccines Product Specification
8.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 FOLIA BIOTECH
8.2.1 FOLIA BIOTECH Company Profile
8.2.2 FOLIA BIOTECH Influenza Vaccines Product Specification
8.2.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Sanofi
8.3.1 Sanofi Company Profile
8.3.2 Sanofi Influenza Vaccines Product Specification
8.3.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 CSL
8.4.1 CSL Company Profile
8.4.2 CSL Influenza Vaccines Product Specification
8.4.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 FluGen
8.5.1 FluGen Company Profile
8.5.2 FluGen Influenza Vaccines Product Specification
8.5.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Company Profile
8.6.2 GlaxoSmithKline Influenza Vaccines Product Specification
8.6.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Green Cross
8.7.1 Green Cross Company Profile
8.7.2 Green Cross Influenza Vaccines Product Specification
8.7.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 BionVax
8.8.1 BionVax Company Profile
8.8.2 BionVax Influenza Vaccines Product Specification
8.8.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Altimmune
8.9.1 Altimmune Company Profile
8.9.2 Altimmune Influenza Vaccines Product Specification
8.9.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Genentech
8.10.1 Genentech Company Profile
8.10.2 Genentech Influenza Vaccines Product Specification
8.10.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 SK Chemicals
8.11.1 SK Chemicals Company Profile
8.11.2 SK Chemicals Influenza Vaccines Product Specification
8.11.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Vaxart
8.12.1 Vaxart Company Profile
8.12.2 Vaxart Influenza Vaccines Product Specification
8.12.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Medicago
8.13.1 Medicago Company Profile
8.13.2 Medicago Influenza Vaccines Product Specification
8.13.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Visterra
8.14.1 Visterra Company Profile
8.14.2 Visterra Influenza Vaccines Product Specification
8.14.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 UNM Pharma
8.15.1 UNM Pharma Company Profile
8.15.2 UNM Pharma Influenza Vaccines Product Specification
8.15.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Shijiazhuang Yiling Pharmaceutical
8.16.1 Shijiazhuang Yiling Pharmaceutical Company Profile
8.16.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
8.16.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Moderna Therapeutics
8.17.1 Moderna Therapeutics Company Profile
8.17.2 Moderna Therapeutics Influenza Vaccines Product Specification
8.17.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Vaxine Pty
8.18.1 Vaxine Pty Company Profile
8.18.2 Vaxine Pty Influenza Vaccines Product Specification
8.18.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Vaccitech
8.19.1 Vaccitech Company Profile
8.19.2 Vaccitech Influenza Vaccines Product Specification
8.19.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.20 Novavax
8.20.1 Novavax Company Profile
8.20.2 Novavax Influenza Vaccines Product Specification
8.20.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Influenza Vaccines (2021-2026)
9.2 Global Forecasted Revenue of Influenza Vaccines (2021-2026)
9.3 Global Forecasted Price of Influenza Vaccines (2015-2026)
9.4 Global Forecasted Production of Influenza Vaccines by Region (2021-2026)
9.4.1 North America Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.3 Europe Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.7 Africa Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.9 South America Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Influenza Vaccines Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Influenza Vaccines by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Influenza Vaccines by Country
10.2 East Asia Market Forecasted Consumption of Influenza Vaccines by Country
10.3 Europe Market Forecasted Consumption of Influenza Vaccines by Countriy
10.4 South Asia Forecasted Consumption of Influenza Vaccines by Country
10.5 Southeast Asia Forecasted Consumption of Influenza Vaccines by Country
10.6 Middle East Forecasted Consumption of Influenza Vaccines by Country
10.7 Africa Forecasted Consumption of Influenza Vaccines by Country
10.8 Oceania Forecasted Consumption of Influenza Vaccines by Country
10.9 South America Forecasted Consumption of Influenza Vaccines by Country
10.10 Rest of the world Forecasted Consumption of Influenza Vaccines by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Influenza Vaccines Distributors List
11.3 Influenza Vaccines Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Influenza Vaccines Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Influenza Vaccines Market Share by Type: 2020 VS 2026
Table 2. Trivalent Flu Vaccines Features
Table 3. Quadrivalent Flu Vaccines Features
Table 11. Global Influenza Vaccines Market Share by Application: 2020 VS 2026
Table 12. Adults Case Studies
Table 13. Pediatrics Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Influenza Vaccines Report Years Considered
Table 29. Global Influenza Vaccines Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Influenza Vaccines Market Share by Regions: 2021 VS 2026
Table 31. North America Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Influenza Vaccines Consumption by Countries (2015-2020)
Table 42. East Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 43. Europe Influenza Vaccines Consumption by Region (2015-2020)
Table 44. South Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 45. Southeast Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 46. Middle East Influenza Vaccines Consumption by Countries (2015-2020)
Table 47. Africa Influenza Vaccines Consumption by Countries (2015-2020)
Table 48. Oceania Influenza Vaccines Consumption by Countries (2015-2020)
Table 49. South America Influenza Vaccines Consumption by Countries (2015-2020)
Table 50. Rest of the World Influenza Vaccines Consumption by Countries (2015-2020)
Table 51. AstraZeneca Influenza Vaccines Product Specification
Table 52. FOLIA BIOTECH Influenza Vaccines Product Specification
Table 53. Sanofi Influenza Vaccines Product Specification
Table 54. CSL Influenza Vaccines Product Specification
Table 55. FluGen Influenza Vaccines Product Specification
Table 56. GlaxoSmithKline Influenza Vaccines Product Specification
Table 57. Green Cross Influenza Vaccines Product Specification
Table 58. BionVax Influenza Vaccines Product Specification
Table 59. Altimmune Influenza Vaccines Product Specification
Table 60. Genentech Influenza Vaccines Product Specification
Table 61. SK Chemicals Influenza Vaccines Product Specification
Table 62. Vaxart Influenza Vaccines Product Specification
Table 63. Medicago Influenza Vaccines Product Specification
Table 64. Visterra Influenza Vaccines Product Specification
Table 65. UNM Pharma Influenza Vaccines Product Specification
Table 66. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
Table 67. Moderna Therapeutics Influenza Vaccines Product Specification
Table 68. Vaxine Pty Influenza Vaccines Product Specification
Table 69. Vaccitech Influenza Vaccines Product Specification
Table 70. Novavax Influenza Vaccines Product Specification
Table 101. Global Influenza Vaccines Production Forecast by Region (2021-2026)
Table 102. Global Influenza Vaccines Sales Volume Forecast by Type (2021-2026)
Table 103. Global Influenza Vaccines Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Influenza Vaccines Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Influenza Vaccines Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Influenza Vaccines Sales Price Forecast by Type (2021-2026)
Table 107. Global Influenza Vaccines Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Influenza Vaccines Consumption Value Forecast by Application (2021-2026)
Table 109. North America Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 110. East Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 111. Europe Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 112. South Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 114. Middle East Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 115. Africa Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 116. Oceania Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 117. South America Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 119. Influenza Vaccines Distributors List
Table 120. Influenza Vaccines Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 2. North America Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 3. United States Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 4. Canada Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 8. China Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 9. Japan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 11. Europe Influenza Vaccines Consumption and Growth Rate
Figure 12. Europe Influenza Vaccines Consumption Market Share by Region in 2020
Figure 13. Germany Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 15. France Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 16. Italy Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 17. Russia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 18. Spain Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 21. Poland Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Influenza Vaccines Consumption and Growth Rate
Figure 23. South Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 24. India Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Influenza Vaccines Consumption and Growth Rate
Figure 28. Southeast Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 29. Indonesia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Influenza Vaccines Consumption and Growth Rate
Figure 37. Middle East Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 38. Turkey Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 40. Iran Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 42. Israel Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 46. Oman Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 47. Africa Influenza Vaccines Consumption and Growth Rate
Figure 48. Africa Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 49. Nigeria Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Influenza Vaccines Consumption and Growth Rate
Figure 55. Oceania Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 56. Australia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 58. South America Influenza Vaccines Consumption and Growth Rate
Figure 59. South America Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 60. Brazil Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 63. Chile Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 65. Peru Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Influenza Vaccines Consumption and Growth Rate
Figure 69. Rest of the World Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 71. Global Influenza Vaccines Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Influenza Vaccines Price and Trend Forecast (2015-2026)
Figure 74. North America Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 75. North America Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 91. South America Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Influenza Vaccines Consumption Forecast 2021-2026
Figure 95. East Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 96. Europe Influenza Vaccines Consumption Forecast 2021-2026
Figure 97. South Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 98. Southeast Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 99. Middle East Influenza Vaccines Consumption Forecast 2021-2026
Figure 100. Africa Influenza Vaccines Consumption Forecast 2021-2026
Figure 101. Oceania Influenza Vaccines Consumption Forecast 2021-2026
Figure 102. South America Influenza Vaccines Consumption Forecast 2021-2026
Figure 103. Rest of the world Influenza Vaccines Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Influenza Vaccines Market Share by Type: 2020 VS 2026
Table 2. Trivalent Flu Vaccines Features
Table 3. Quadrivalent Flu Vaccines Features
Table 11. Global Influenza Vaccines Market Share by Application: 2020 VS 2026
Table 12. Adults Case Studies
Table 13. Pediatrics Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Influenza Vaccines Report Years Considered
Table 29. Global Influenza Vaccines Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Influenza Vaccines Market Share by Regions: 2021 VS 2026
Table 31. North America Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Influenza Vaccines Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Influenza Vaccines Consumption by Countries (2015-2020)
Table 42. East Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 43. Europe Influenza Vaccines Consumption by Region (2015-2020)
Table 44. South Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 45. Southeast Asia Influenza Vaccines Consumption by Countries (2015-2020)
Table 46. Middle East Influenza Vaccines Consumption by Countries (2015-2020)
Table 47. Africa Influenza Vaccines Consumption by Countries (2015-2020)
Table 48. Oceania Influenza Vaccines Consumption by Countries (2015-2020)
Table 49. South America Influenza Vaccines Consumption by Countries (2015-2020)
Table 50. Rest of the World Influenza Vaccines Consumption by Countries (2015-2020)
Table 51. AstraZeneca Influenza Vaccines Product Specification
Table 52. FOLIA BIOTECH Influenza Vaccines Product Specification
Table 53. Sanofi Influenza Vaccines Product Specification
Table 54. CSL Influenza Vaccines Product Specification
Table 55. FluGen Influenza Vaccines Product Specification
Table 56. GlaxoSmithKline Influenza Vaccines Product Specification
Table 57. Green Cross Influenza Vaccines Product Specification
Table 58. BionVax Influenza Vaccines Product Specification
Table 59. Altimmune Influenza Vaccines Product Specification
Table 60. Genentech Influenza Vaccines Product Specification
Table 61. SK Chemicals Influenza Vaccines Product Specification
Table 62. Vaxart Influenza Vaccines Product Specification
Table 63. Medicago Influenza Vaccines Product Specification
Table 64. Visterra Influenza Vaccines Product Specification
Table 65. UNM Pharma Influenza Vaccines Product Specification
Table 66. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
Table 67. Moderna Therapeutics Influenza Vaccines Product Specification
Table 68. Vaxine Pty Influenza Vaccines Product Specification
Table 69. Vaccitech Influenza Vaccines Product Specification
Table 70. Novavax Influenza Vaccines Product Specification
Table 101. Global Influenza Vaccines Production Forecast by Region (2021-2026)
Table 102. Global Influenza Vaccines Sales Volume Forecast by Type (2021-2026)
Table 103. Global Influenza Vaccines Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Influenza Vaccines Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Influenza Vaccines Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Influenza Vaccines Sales Price Forecast by Type (2021-2026)
Table 107. Global Influenza Vaccines Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Influenza Vaccines Consumption Value Forecast by Application (2021-2026)
Table 109. North America Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 110. East Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 111. Europe Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 112. South Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 114. Middle East Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 115. Africa Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 116. Oceania Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 117. South America Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Influenza Vaccines Consumption Forecast 2021-2026 by Country
Table 119. Influenza Vaccines Distributors List
Table 120. Influenza Vaccines Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 2. North America Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 3. United States Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 4. Canada Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 8. China Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 9. Japan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 11. Europe Influenza Vaccines Consumption and Growth Rate
Figure 12. Europe Influenza Vaccines Consumption Market Share by Region in 2020
Figure 13. Germany Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 15. France Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 16. Italy Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 17. Russia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 18. Spain Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 21. Poland Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Influenza Vaccines Consumption and Growth Rate
Figure 23. South Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 24. India Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Influenza Vaccines Consumption and Growth Rate
Figure 28. Southeast Asia Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 29. Indonesia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Influenza Vaccines Consumption and Growth Rate
Figure 37. Middle East Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 38. Turkey Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 40. Iran Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 42. Israel Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 46. Oman Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 47. Africa Influenza Vaccines Consumption and Growth Rate
Figure 48. Africa Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 49. Nigeria Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Influenza Vaccines Consumption and Growth Rate
Figure 55. Oceania Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 56. Australia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 58. South America Influenza Vaccines Consumption and Growth Rate
Figure 59. South America Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 60. Brazil Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 63. Chile Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 65. Peru Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Influenza Vaccines Consumption and Growth Rate
Figure 69. Rest of the World Influenza Vaccines Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Influenza Vaccines Consumption and Growth Rate (2015-2020)
Figure 71. Global Influenza Vaccines Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Influenza Vaccines Price and Trend Forecast (2015-2026)
Figure 74. North America Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 75. North America Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 91. South America Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Influenza Vaccines Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Influenza Vaccines Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Influenza Vaccines Consumption Forecast 2021-2026
Figure 95. East Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 96. Europe Influenza Vaccines Consumption Forecast 2021-2026
Figure 97. South Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 98. Southeast Asia Influenza Vaccines Consumption Forecast 2021-2026
Figure 99. Middle East Influenza Vaccines Consumption Forecast 2021-2026
Figure 100. Africa Influenza Vaccines Consumption Forecast 2021-2026
Figure 101. Oceania Influenza Vaccines Consumption Forecast 2021-2026
Figure 102. South America Influenza Vaccines Consumption Forecast 2021-2026
Figure 103. Rest of the world Influenza Vaccines Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
